Virucidal activity against RNA-containing equine infectious anemia virus (EIAV) at a concentration of 0.1 ug/mL by using a focal immunoassay in the light; Activity expressed as log FFU/mL
Virucidal activity against RNA-containing equine infectious anemia virus (EIAV) at a concentration of 1.0 ug/mL by using a focal immunoassay in the light; Activity expressed as log FFU/mL
Virucidal activity against RNA-containing equine infectious anemia virus (EIAV) at a concentration of 10 ug/mL by using a focal immunoassay in the dark; Activity expressed as log FFU/mL
Virucidal activity against RNA-containing equine infectious anemia virus (EIAV) at a concentration of 10 ug/mL by using a focal immunoassay; Activity expressed as log FFU/mL
Antiviral activity against equine infectious anemia virus (EIAV) in deoxygenation condition effected by using beta-carotene at a concentration of 32 uM
Antiviral activity against equine infectious anemia virus (EIAV) in deoxygenation condition effected by using beta-carotene at a concentration of 64 uM
Antiviral activity against equine infectious anemia virus (EIAV) in deoxygenation condition effected by using beta-carotene at a concentration of 80 uM
Antiviral activity against equine infectious anemia virus (EIAV) in hypoxic condition obtained by passing argon gas, after 0 min of illumination, using focal immunoassay
Antiviral activity against equine infectious anemia virus (EIAV) in hypoxic condition obtained by passing argon gas, after 10 min of illumination, using focal immunoassay
Antiviral activity against equine infectious anemia virus (EIAV) in hypoxic condition obtained by passing nitrogen gas, after 0 min of illumination using focal, immunoassay
Antiviral activity against equine infectious anemia virus (EIAV) in hypoxic condition obtained by passing nitrogen gas, after 10 min of illumination using focal, immunoassay